(Q44474376)
Statements
Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial (English)
Claudio Borghi
Maria Grazia Prandin
Ada Dormi
Ettore Ambrosioni
Study Group of the Regional Unit of the Italian Society of Hypertension